about
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialThe potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivoLiposomes as nanomedical devicesLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells.Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesmRNA vaccine delivery using lipid nanoparticles.Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomesAn integrative omics strategy to assess the germ cell secretome and to decipher sertoli-germ cell crosstalk in the Mammalian testis.Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency.Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs.Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model.Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation.Nanoliposomes: Synthesis methods and applications in cosmetics.Biodistribution and delivery efficiency of unmodified tumor-derived exosomesThe effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes.Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes.Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.Liposome opsonization.Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriersSurface-active liposomes for targeted cancer therapy.Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.Past and future evolution in colloidal drug delivery systems.Antibody-targeted liposomes in cancer therapy and imaging.Lipid nature and their influence on opening of redox-active liposomes.Surface engineering of liposomes for stealth behavior.Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.Recent advances in tumor vasculature targeting using liposomal drug delivery systems.Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7.An appraisal of the published literature on the safety and toxicity of food-related nanomaterials.Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity.Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy.Recent advances in stealth coating of nanoparticle drug delivery systemsOptimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.Nanoliposome-based antibacterial drug delivery.
P2860
Q24657256-C5EAAFFB-96B4-44AA-9C67-5190419BAEF8Q26827175-BDF5734F-4D56-455B-969F-3A2A352850FAQ28088315-ABD7588E-252A-44B2-98C9-2A379E3C2C1FQ30366990-974FDA6F-5EDB-4B05-92D6-914408F7DC9CQ30427317-F118B100-32AF-43AF-8962-62F073542FA9Q33651796-4F60F931-532E-4AC3-B510-F709310CD337Q33664307-E2181266-DBB9-4B57-AC7D-F56E0B294EDCQ33711685-13AA8DD7-64A8-43A8-8E1E-C59E562D8FBDQ33925578-BB268079-D36B-43DE-B746-B6826A36D751Q33959996-CC6446B2-F9EC-466C-BC42-382D5B90B5B1Q34027634-CFB345BB-D4EA-472E-A8A4-06A14391C7FFQ34146469-9A4F09C1-F71C-492A-B067-DE0EBE3E0F90Q34557950-C2B0A824-9EE7-4043-86AA-DD43B0527830Q34571360-6E28D52D-CF07-479B-9EEF-61C0F8EB243FQ35110669-B56F90AA-A63D-41CD-96AF-0541076920E8Q35567800-59E5A77E-164F-4928-882E-3B6C09EEBEA0Q35629111-6C3C4799-2DFF-4A5A-99FA-8CCF2CD7B86CQ35636629-A4625DAE-08F8-495E-8527-FE666477E823Q35669424-B129BE9B-71F2-4ECB-AE26-010BFD766319Q36070727-2EAEDC65-4690-4EB6-BAD1-3BA9E071FB5BQ36125194-392037FE-E86B-4A30-9092-46A9061F8A95Q36272611-7D342426-F50F-4028-A126-2082CE30D3F2Q36792020-F35ABCB7-1ED8-4F44-B138-90215A86C5DCQ36831931-963F4E61-A30C-437F-95E2-CABA6802790EQ36988355-096492C1-183D-4FE3-B127-E01FAD419952Q37020672-231BAD5D-36D6-438C-94F3-D253879D2074Q37039030-6EC0101A-A85F-4AB0-AFA6-E9000639633DQ37076367-25915AF1-0101-4A8E-9231-F784C46E2F01Q37186746-99358F19-1661-4654-8196-87050E33B9F1Q37415968-573C3331-1CBE-41B1-B79B-3AE6EA90CEB6Q37577552-413F47CD-EFC3-4221-B573-F78C2DC41D39Q37603355-206D3DF4-0804-4BA8-BDAE-09211E7CFE0CQ37689857-772307D5-3FA3-44EC-8F72-5188734A6FEEQ37695142-E266C06E-5C25-4E15-A78A-ECAD5A4D94E2Q37809539-BE845F03-2EF2-4C72-B213-7B564F3AE93EQ37865021-937D8C31-0961-41F7-8BBF-74052C4B3195Q37942172-C285C66A-A67E-42A8-BEC0-52E099E591F5Q37974590-31F58B0B-D527-4B82-BD85-333C513E56D7Q37999793-0A910A35-5E81-4BC1-B03D-E6C2C32A9F76Q38169247-0CDCD0AE-96F9-4F49-B689-86273FF8C134
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Liposome clearance.
@ast
Liposome clearance.
@en
Liposome clearance.
@nl
type
label
Liposome clearance.
@ast
Liposome clearance.
@en
Liposome clearance.
@nl
prefLabel
Liposome clearance.
@ast
Liposome clearance.
@en
Liposome clearance.
@nl
P2093
P356
P1433
P1476
Liposome clearance.
@en
P2093
Hideyoshi Harashima
Hiroshi Kiwada
Tatsuhiro Ishida
P2888
P304
P356
10.1023/A:1020134521778
P577
2002-04-01T00:00:00Z
P6179
1038757431